Delex Therapeutics, Inc.
9B03N011
-
- 1,99 €
-
- 1,99 €
Description de l’éditeur
Delex Therapeutics Inc. researches and develops drug delivery methods - specifically in pain management - called rapid onset and sustained effect delivery system. The company is seeking funds to support its research and development. A partner at a venture firm that focuses on companies in the health care and biotechnology sectors must assess the investment merits of Delex Therapeutics as it embarks on phase II clinical trials.
GENRE
Entreprise et management
SORTIE
2003
28 novembre
LANGUE
EN
Anglais
LONGUEUR
17
Pages
ÉDITIONS
Richard Ivey School of Business Foundation
DÉTAILS DU FOURNISSEUR
Ivey Business School Foundation Foundation
TAILLE
1,3
Mo
Ontario Formulary
2005
Agennix AG Gets Positive Results from Talactoferrin Trial
2010
Solnyx Pharmaceuticals: The Atoxeril Clinical Trial
2005
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
2021
How Drug Testing Works
2022
A Study on the State of the Biopharmaceutical Sector in India with Emphasis on Its Exports (Articles for Volume 5, Number 1) (Report)
2009